Literature DB >> 21448792

Functional restoration of endothelial cells of the cryopreserved heart valve.

Eiki Fujimoto1, Masanori Yoshizumi, Tamotsu Kanbara, Hirotsugu Kurobe, Tatsuo Motoki, Mikio Sugano, Taisuke Nakayama, Takashi Kitaichi, Tetsuya Kitagawa.   

Abstract

PURPOSE: Although several approaches have been tried to improve the durability of cryopreserved valves, cellular restoration after thawing remains to be investigated. The aim of our study was to assess the functional restoration of endothelial cells of cryopreserved heart valves by in vitro culture for an alternative step to improving longevity.
METHODS: Cryopreserved human umbilical vein endothelial cells (HUVECs) and porcine aortic cusps were cultivated for 14 days after thawing. Then the cellular activity of the enzymes cytosolic esterase and mitochondrial dehydrogenase was measured. The cellular viability of cryopreserved cusps was also assessed using confocal laser scanning microscopy.
RESULTS: The number of viable HUVECs decreased markedly after cryopreservation and thawing but recovered to pre-cryopreservation level after 14 days of culture. In contrast, the enzyme activity of the cryopreserved porcine aortic cusps showed recovery at 7 days of in vitro tissue culture after thawing. Confocal laser scanning microscopy findings showed that the cellular cytosolic esterase activity of cryopreserved cusps deteriorated after thawing but displayed considerable recovery by day 14 of culture.
CONCLUSION: The functional recovery of endothelial cells in cryopreserved heart valves seems to require tissue culture of at least 14 days. Ex vivo endothelial restoration of cryopreserved heart valves may add to heart valve durability.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21448792     DOI: 10.1007/s11748-010-0711-y

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  30 in total

1.  Pathology of fresh versus cryopreserved homograft heart valves.

Authors:  Jean François Légaré
Journal:  J Thorac Cardiovasc Surg       Date:  2004-06       Impact factor: 5.209

2.  Tissue chimerism in human cryopreserved homograft valve explants demonstrated by in situ hybridization.

Authors:  D R Koolbergen; M G Hazekamp; M Kurvers; E de Heer; C J Cornelisse; H A Huysmans; J A Bruijn
Journal:  Ann Thorac Surg       Date:  1998-12       Impact factor: 4.330

3.  Prevention of allograft heart valve failure in a rat model.

Authors:  J F Légaré; D B Ross; T B Issekutz; W Ruigrok; K Creaser; G M Hirsch; T D Lee
Journal:  J Thorac Cardiovasc Surg       Date:  2001-08       Impact factor: 5.209

4.  Effect of cryopreservation on the presence of endothelial cells on human valve allografts.

Authors:  F M Lupinetti; T T Tsai; J M Kneebone; E L Bove
Journal:  J Thorac Cardiovasc Surg       Date:  1993-11       Impact factor: 5.209

5.  Biochemical and cellular characterization of cardiac valve tissue after cryopreservation or antibiotic preservation.

Authors:  S J Lang; M S Giordano; C Cardon-Cardo; B D Summers; L Staiano-Coico; D P Hajjar
Journal:  J Thorac Cardiovasc Surg       Date:  1994-07       Impact factor: 5.209

6.  Superior durability of SynerGraft pulmonary allografts compared with standard cryopreserved allografts.

Authors:  Zarry Tavakkol; Sarah Gelehrter; Caren S Goldberg; Edward L Bove; Eric J Devaney; Richard G Ohye
Journal:  Ann Thorac Surg       Date:  2005-11       Impact factor: 4.330

7.  Anti-HLA antibodies after cryopreserved allograft valve implantation does not predict valve dysfunction at three-year follow up.

Authors:  Cheng-Hon Yap; Peter D Skillington; George Matalanis; Bruce B Davis; Brian D Tait; Fiona Hudson; Lyn Ireland; Ian Nixon; Michael Yiil
Journal:  J Heart Valve Dis       Date:  2006-07

8.  Factors in the early failure of cryopreserved homograft pulmonary valves in children: preserved immunogenicity?

Authors:  R J Baskett; D B Ross; M A Nanton; D A Murphy
Journal:  J Thorac Cardiovasc Surg       Date:  1996-11       Impact factor: 5.209

9.  Effect of warm ischemia and cryopreservation on cell viability of human allograft valves.

Authors:  K Niwaya; H Sakaguchi; K Kawachi; S Kitamura
Journal:  Ann Thorac Surg       Date:  1995-08       Impact factor: 4.330

10.  Mid-term clinical results using a tissue-engineered pulmonary valve to reconstruct the right ventricular outflow tract during the Ross procedure.

Authors:  Pascal M Dohmen; Alexander Lembcke; Sebastin Holinski; Dietmar Kivelitz; Jan P Braun; Axel Pruss; Wolfgang Konertz
Journal:  Ann Thorac Surg       Date:  2007-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.